Tilray Brands

Tilray Brands (NASDAQ:TLRY) remains a cautious investment, according to Zuanic & Associates, despite its solid balance sheet and diverse global assets. With a "Neutral" rating, Zuanic views Tilray as a long-term player in the cannabis sector, though short-term uncertainties cloud its outlook....

In a fireside chat with senior analyst Pablo Zuanic on October 23, 2024, Tilray Brands (NASDAQ:TLRY) CEO Irwin Simon shared insights into the company's growth strategies, highlighting profitability, U.S. market entry and the expansion of their cannabis and beverage businesses. Simon also addressed...

Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced a series of fall-themed product launches across its craft beer and beverage brands on Wednesday, including Breckenridge Brewery, Montauk Brewing, Blue Point Brewing, Terrapin and Shock Top. The Canadian cannabis giant has been buying beer...

Tilray Brands, Inc. (NASDAQ:TLRY) bought four craft breweries from Molson Coors Beverage Company. The breweries included in this deal are Hop Valley Brewing Company, Terrapin Beer Co., Revolver Brewing, and Atwater Brewery. This expansion helps Tilray grow its reach into important U.S. regions...

A new study conducted by a division of Tilray Brands, Inc. (NASDAQ:TLRY) reveals that a substantial majority of medical marijuana patients over the age of 50 are utilizing cannabis to manage chronic pain and arthritis. This research highlights the growing trend among older adults turning to...

New York Legal Recreational Cannabis Sales are just around the corner. Following this movement, state regulators recently greenlighted the first 36 for conditional adult-use retail dispensary licenses. Separately, Governor Kathy Hochul recently signed a bill that aims to expand the state's hemp...

Although the CDC estimates that 48.2 million Americans (18 percent of the population) used cannabis in 2019, at least eight states have passed laws prohibiting the denial of a transplant solely on the basis of marijuana use. Due to the lack of consensus among medical experts about cannabis use and...